Treatment outcome in children with central nervous system-positive Burkitt lymphoma using only intrathecal and systemic chemotherapy combined with rituximab

BACKGROUND: With current chemotherapy treatment, >90% of survival has been obtained for Burkitt lymphoma (BL). In this study, the demographic characteristics and treatment outcomes are presented for 78 children in China with central nervous system-positive (CNS+) BL. METHODS: This retrospective s...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Shuang, Jin, Lin, Yang, Jing, Duan, Yan-Long, Zhang, Meng, Zhou, Chun-Ju, Zhang, Yong-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183724/
https://www.ncbi.nlm.nih.gov/pubmed/33734131
http://dx.doi.org/10.1097/CM9.0000000000001386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183724/
https://www.ncbi.nlm.nih.gov/pubmed/33734131
http://dx.doi.org/10.1097/CM9.0000000000001386

Ejemplares similares